NCT02298270View on ClinicalTrials.gov

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
NeurofibromatosisNeurofibromatosis INeurofibromatosis 2Schwannomatosis
Interventions
BEHAVIORAL

The Relaxation Response Resiliency Program (3RP) via Skype

8-week group intervention, delivered via Skype, teaching relaxation and psychological resiliency enhancing skills. Topics include the relaxation response, meditation, and yoga.

Trial Locations (1)

02140

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

The Children's Tumor Foundation

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02298270 - Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype | Biotech Hunter | Biotech Hunter